Top Abstract Purchase Related
Home
>
Node
>
Subnode

The trials of no-transport

Shanaberger, C.J.

Jems a Journal of Emergency Medical Services 17(2): 75-76

1992

ISSN/ISBN: 0197-2510
PMID: 10183616
Document Number: 393904
The decision of the HHS Departmental Appeals Board Appellate Division in Inspector General v. Hanlester Network provides guidance as to the aspects of joint ventures that pose fraud and abuse concerns by listing the factors that may indicate an improper purpose. Together with the fraud and abuse safe harbors, the decision helps identify the pitfalls associated with physician investment in suspect joint ventures. This article analyzes the latest Hanlester decision, forecasts the future of joint venturing after Hanlester and the safe harbors, and offers some guidance to potential investors in light of these developments.

Document emailed within 1 workday
Secure & encrypted payments

Richman, D.; Itri, L.; Johnson, M.F.; Eigo, J. 1990: Methodological issues in AIDS clinical trials. Discussion. Design of clinical trials--active control (equivalence) trials Journal of Acquired Immune Deficiency Syndromes 3 Suppl. 2: S88
Li, Y.-s. 2010: To modify the design of preclinical trials: a lesson from the failure of neuroprotection trials in stroke Zhonghua Nei Ke Za Zhi 49(9): 733-734
Cheson, B.D.; Phillips, P.H.; Trimble, E. 1994: Clinical trials. Referral resource. Phase Ii Ovarian Cancer Trials Oncology 8(4): 73-74
Trimble, E.L.; Schoenfeldt, M. 2004: Clinical trials referral source. Current randomized phase IIi trials in gynecologic cancer Oncology 18(13): 1642; 1645-1646
Dhalla, S.; Poole, G. 2014: Effect of race/ethnicity on participation in HIV vaccine trials and comparison to other trials of biomedical prevention Human Vaccines and Immunotherapeutics 10(7): 1974-1984
Klemt, W.D.; Metschies, G.; Ramalho, L. 1984: Transportsysteme in Entwicklungsländern. Angepasste Verkehrspolitik für Städte - das Beispiel Conakry/Guinea - Systèmes de transport dans les pays en voie de développement. Politique des transports adaptée pour les villes. Exemple de Conakry (Guinée) - Transport systems in developing countries. Adapted urban transport policy, as exemplified by Conakry-Guinea Internationales Verkehrswesen 36(2): 94-99
Cheson, B.D.; Carter, C.L.; Sznol, M. 1993: Clinical trials referral resource. NCI-sponsored trials of interleukin-6 (IL-6) Oncology 7(6): 43-44
Saxman, S.B.; Smiley, J.K.; Cheson, B.D. 1999: Clinical trials referral resource. Current trials in melanoma Oncology 13(9): 1239-1242
Lietman, P.; Temple, R.; Harrington, M.; Peck, C. 1990: Methodological issues in AIDS clinical trials. Discussion. Design of clinical trials--approaches to clinical trials design Journal of Acquired Immune Deficiency Syndromes 3 Suppl. 2: S27
Sobiecka, D.; Waniewski, J.; Weryński, A.; Lindholm, B. 2004: Peritoneal fluid transport in CAPD patients with different transport rates of small solutes Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 24(3): 240-251
Crevoisier, C.; Buri, P.; Boucherat, J. 1975: The transport of three flavonoids across artificial and biological membranes. 5. Transport in situ across the small intestine of the rat Pharmaceutica Acta Helvetiae 50(7-8): 231-236
Lassánová, M.; Brechtlová, M. 1971: Transport of L-glutamate and glycine in cells of rat cerebral cortex slices kinetics of transport Physiologia Bohemoslovaca 20(3): 235-240
Crevoisier, C.; Buriet, P.; Boucherat, J. 1974: The transport of three flavonoids through artificial and biological membranes. the transport in vitro through a cellophane membrane Pharmaceutica Acta Helvetiae 49(3-4): 140-151
Crevoisier, C.; Buri, P.; Boucherat, J. 1974: The transport of 3 flavonoids through artificial and biological membranes. First communication. In vitro transport through a cellophane membrane Pharmaceutica Acta Helvetiae 49(3-4): 140-151
Steffen, K.M.; Noje, C.; Costabile, P.M.; Henderson, E.; Hunt, E.A.; Klein, B.L.; McMillan, K.Nelson. 2020: Pediatric Transport Triage: Development and Assessment of an Objective Tool to Guide Transport Planning Pediatric Emergency Care 36(5): 240-247
Bellamy, N.; Carette, S.; Ford, P.M.; Kean, W.F.; le Riche, N.G.; Lussier, A.; Wells, G.A.; Campbell, J. 1992: Osteoarthritis antirheumatic drug trials. III. Setting the delta for clinical trials--results of a consensus development (Delphi) exercise Journal of Rheumatology 19(3): 451-457
Moher, D. 1998: CONSORT: an evolving tool to help improve the quality of reports of randomized controlled trials. Consolidated Standards of Reporting Trials JAMA 279(18): 1489-1491
Strauss, P.R.; Sheehan, J.M.; Kashket, E.R. 1977: Membrane transport by murine lymphocytes. II. the appearance of thymidine transport in cells from concanavalin A-stimulated mice Journal of Immunology 118(4): 1328-1334
Cuesta Casado, M.C.; Ramos, E.H. 1981: Regulation of amino acid transport into Ehrlich cells. Effect of 3',5'-adenosine monophosphate on L-leucine transport Cellular and Molecular Biology Including Cyto-Enzymology 27(6): 635-641
Kaitwatcharachai, C.; Aden, J.; Kongkid, K.; Kitpiboonchai, T.; Kaitwatcharachai, S. 2011: Determination of peritoneal membrane transport characteristics with dialysis adequacy and transport test in Thai patients Journal of the Medical Association of Thailand 94(Suppl 4): S81-S86